By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that its second-quarter 2012 revenues increased 22 percent year over year with molecular diagnostic revenues up 17 percent.

The Salt Lake City-based firm had total revenues of $122.8 million for the three-month period ended Dec. 31, 2011, compared to $100.4 million for the second quarter of 2011. It beat Wall Street's consensus estimate for revenues of $115.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.